Skip to main content

Table 3 Prevalence of MetS by definition

From: Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa—a systematic review and meta-analysis

 

Author and publication year

HIV status

Prevalence by definition criteria

HIV+

HIV−

IDF

ATP

Others

1

Amusa et al., 2016 [33]

150

50

NA

NA

41 (27.3%), P < 0.01Ϯ

2 (4%), P < 0.01α—not stated

2

Ayodele et al., 2012 [32]

291

NA

50 (17.2%)

37 (12.7%)

61(21.0%)—JIS

3

Berhane et al., 2012 [34]

313

NA

NA

66 (21.1%)

NA

4

Tesfaye et al., 2014 [42]

374

NA

23.8%

16.8%

NA

5

Sobieszczyk et al., 2016 [29]

160

NA

NA

27 (8.7%)

NA

6

Obirikorang et al., 2016 [41]

433

NA

183 (42.3%)

209 (48.3%)

106 (24.5%)—WHO

7

Ngatchou et al., 2013 [40]

108

96

47.0%, P = 0.02Ϯ

21.0%, P = 0.02α

NA

NA

8

Fourie et al., 2010 [35]

300

300

21.1%, P = 0.65Ϯ

22.6%, P = 0.65α

15.2% P = 0.18Ϯ

11.5% P = 0.18α

NA

9

Muhammad et al., 2013 [45]

200

NA

ART = 21.0%;

Naive = 9.0%

P = 0.017

NA

NA

10

Mbunkah et al., 2014 [38]

173

50

NA

15.6% (27/173) (P = 0.020)Ϯ

8.0% (4/50)α

NA

11

Guehi et al., 2016 [30]

755

NA

NA

47 (6.2%) P > 0.0001

NA

12

Mashinya et al., 2015 [37]

214

NA

NA

20 (9.6%) P = 0.56

NA

13

Guira et al., 2016 [31]

300

NA

54 (18.0%)

NA

NA

14

Hirigo et al., 2016 [36]

185

NA

24.3% (45/185)

17.8%

NA

15

Zannou et al., 2009 [28]

79

NA

10 (12.7%)

NA

NA

16

Muyanja et al., 2016 [39]

250

NA

NA

145/250 (58.0%) P value = 0.10

NA

  1. ,NA not applicable
  2. αHIV-negative
  3. ϮHIV-positive